Showing 181 - 200 results of 746 for search '"rheumatoid arthritis"', query time: 0.07s Refine Results
  1. 181
  2. 182

    Intertoe Squamous Cell Carcinoma Developed in a Patient with Rheumatoid Arthritis under Etanercept Therapy by Efstathios Rallis, Vasiliki-Kalliopi Bournia, Constantinos Verros, Alexios Iliopoulos

    Published 2015-01-01
    “…We present here the case of a 75-year-old woman with rheumatoid arthritis, who developed an intertoe squamous cell carcinoma (SCC) of the right foot. …”
    Get full text
    Article
  3. 183
  4. 184

    Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritis by Lakshmi Deepika Yarlagadda, Rachel Jacob, D Liza Rajasekhar, Krishna Mohan Iyyapu, Sai Baba S S. Kompella, Vijaya Bhaskar Madrol, N N Sreedevi, Siraj Ahmed Khan, Noorjahan Mohammed

    Published 2020-01-01
    “…Context: The lack of sensitivity and specificity of the existing diagnostic markers in Rheumatoid arthritis (RA) stimulates the search for new biomarkers to improve diagnostic sensitivity especially in seronegative cases. …”
    Get full text
    Article
  5. 185
  6. 186
  7. 187
  8. 188

    Effectiveness of nurse-led care in patients with rheumatoid arthritis: a systematic review and meta-analysis by Dan Liu, Li Liu, Lin Yang, Ting Wen, Peng Xiang, Guifang Pi

    Published 2025-01-01
    “…Objectives This study sought to assess the effectiveness of nurse-led care (NLC) in patients with rheumatoid arthritis (RA).Methods We conducted a comprehensive search of the Cochrane Library, Web of Science, PubMed, Embase, CINAHL, ClinicalTrials.gov databases and the references from relevant literature published prior to May 2023. …”
    Get full text
    Article
  9. 189
  10. 190

    Anti-Interleukin-6 Receptor Antibody Therapy-Induced Retinopathy in a Patient with Rheumatoid Arthritis by Asumi Tada, Noriyasu Hashida, Toshio Tanaka, Kohji Nishida

    Published 2012-01-01
    “…Tocilizumab, a humanized anti-human interleukin-6 (IL-6) receptor monoclonal antibody, is beneficial for treating autoimmune conditions such as rheumatoid arthritis (RA). The most common adverse event is upper respiratory tract infection; ocular side effects are rare. …”
    Get full text
    Article
  11. 191

    Lung Sarcoidosis in Etanercept Treated Rheumatoid Arthritis Patient: A Case Report and Review of the Literature by Supat Thongpooswan, Adriana Abrudescu

    Published 2014-01-01
    “…We report a 55-year-old female with seropositive rheumatoid arthritis for 10 years who developed large mediastinal and hilar adenopathy while receiving etanercept therapy. …”
    Get full text
    Article
  12. 192

    Efficacy of Abatacept for Arthritis in Patients with an Overlap Syndrome between Rheumatoid Arthritis and Systemic Lupus Erythematosus by Kei Ikeda, Yoshie Sanayama, Sohei Makita, Junichi Hosokawa, Mieko Yamagata, Daiki Nakagomi, Katsuhiko Takabayashi, Hiroshi Nakajima

    Published 2013-01-01
    “…This study aimed to investigate the efficacy of abatacept for arthritis in patients with rhupus, an overlap syndrome between rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). …”
    Get full text
    Article
  13. 193
  14. 194
  15. 195
  16. 196

    Could Biomarkers of Bone, Cartilage or Synovium Turnover Be Used for Relapse Prediction in Rheumatoid Arthritis Patients? by Delphine Dénarié, Elodie Constant, Thierry Thomas, Hubert Marotte

    Published 2014-01-01
    “…The aim of this review is to clarify the usefulness of bone, cartilage, and synovial biomarker in the management of rheumatoid arthritis (RA) therapy in remission. Synovial Biomarkers. …”
    Get full text
    Article
  17. 197

    The Association of TNF-Alpha Inhibitors and Development of IgA Nephropathy in Patients with Rheumatoid Arthritis and Diabetes by Vedran Premužić, Ivan Padjen, Mislav Cerovec, Marijana Ćorić, Bojan Jelaković, Branimir Anić

    Published 2020-01-01
    “…We are reporting three patients with longstanding rheumatoid arthritis (RA), which developed IgAN while receiving TNF-alpha inhibitors. …”
    Get full text
    Article
  18. 198
  19. 199
  20. 200